吸入鎮静剤の世界市場レポート 2025年

吸入鎮静剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で28億8,000万米ドルに成長します。予測期間の成長は、外来患者処置、麻酔デリバリーシステム、遠隔医療と遠隔モニタリング、呼吸器疾患の有病率の増加、外来手術センターの拡大などの需要増に起因しています。予測期間の主な動向には、非薬物療法による代替、持続可能性と環境に優しい実践、データ統合と人工知能、医療技術の進歩などがあります。

吸入鎮静剤の迅速な作用と短い持続時間は、吸入鎮静薬市場を促進すると予想されます。特に小児歯科手術や集中治療室での疼痛管理と迅速な回復に適しています。一般的に使用されている吸入鎮静剤である亜酸化窒素は、通常30～70％の酸素混合物として投与され、作用に1～2分かかり、約5分間持続します。その即効性と持続時間の短さから、歯科治療用の鎮静剤として好まれ、その迅速な効能により吸入鎮静剤の需要を牽引しています。

呼吸器疾患の有病率の増加は、吸入鎮静剤市場の今後の成長を後押しすると予想されます。呼吸器疾患とは、肺、気管支、気管、喉頭、咽頭、鼻腔を含む呼吸器系に影響を及ぼす病状を指します。吸入鎮静剤は、これらの疾患の管理において、不安の軽減、患者の快適性の向上、医療処置の円滑化、呼吸および呼吸機能全般の改善など、さまざまな目的を達成するために利用されます。例えば、2024年3月、米国政府機関であるCDC（Centers for Disease Control and Prevention）は、結核患者数が2022年の8,320人から2023年には9,615人と1,295人増加したと報告しています。したがって、呼吸器系疾患の罹患率の増加が、吸入鎮静剤の今後の市場を牽引する可能性が高いです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界吸入鎮静剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の吸入鎮静剤市場：成長率分析
• 世界の吸入鎮静剤市場の実績：規模と成長, 2019-2024
• 世界の吸入鎮静剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界吸入鎮静剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の吸入鎮静剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• セボフルラン
• デスフルラン
• イソフルラン
• 亜酸化窒素
• 世界の吸入鎮静剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 誘導
• メンテナンス
• 世界の吸入鎮静剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• その他のエンドユーザー
• 世界の吸入鎮静剤市場セボフルランの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児麻酔
• 成人麻酔
• 世界の吸入鎮静剤市場デスフルランの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外来手術
• 維持麻酔
• 世界の吸入鎮静剤市場イソフルランの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全身麻酔の維持
• 全身麻酔の導入
• 世界の吸入鎮静剤市場亜酸化窒素の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 歯科処置のための鎮痛剤
• 軽度の外科手術のための麻酔

第7章 地域別・国別分析

• 世界の吸入鎮静剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の吸入鎮静剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 吸入鎮静剤市場：競合情勢
• 吸入鎮静剤市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Halocarbon Products Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Hikma Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Jiangsu Hengrui Medicine Co. Ltd.
• Lunan Pharmaceutical Group Co. Ltd.
• Novartis International AG
• Piramal Enterprises Ltd.
• Troikaa Pharmaceuticals Ltd.
• AstraZeneca plc
• Boehringer Ingelheim International GmbH
• Merck & Co. Inc.
• Pfizer Inc.
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Lupin Limited
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 吸入鎮静剤市場2029：新たな機会を提供する国
• 吸入鎮静剤市場2029：新たな機会を提供するセグメント
• 吸入鎮静剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Inhalation sedatives are relaxant agents administered through a nose mask. At higher doses, they can function as general anesthetics, induce a state of calmness, and even aid in the treatment of sleep disorders. Inhalation sedation involves the continual delivery of a tranquilizer via a nose mask and is colloquially known as 'happy gas,' 'laughing gas,' or 'conscious sedation.' The gas typically used is nitrous oxide.

The primary products in the inhalation sedatives market include sevoflurane, desflurane, isoflurane, and nitrous oxide. Sevoflurane, for instance, is a nonflammable, highly fluorinated methyl isopropyl ether with a sweet scent, often employed as an inhalational anesthetic for both the induction and maintenance of general anesthesia. These sedatives find applications in various procedures such as induction and maintenance across different healthcare sectors, including hospitals, ambulatory surgical centers, and other medical facilities where anesthesia is required.

The inhalation sedatives market research report is one of a series of new reports from The Business Research Company that provides inhalation sedatives market statistics, including inhalation sedatives industry global market size, regional shares, competitors with inhalation sedatives market share, detailed inhalation sedatives market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation sedatives industry. This inhalation sedatives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The inhalation sedatives market size has grown steadily in recent years. It will grow from $2.24 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, growing geriatric population, rising awareness of inhalation sedatives, increasing investment in research and development, expanding pipeline of inhalation sedatives, surgical procedures.

The inhalation sedatives market size is expected to see strong growth in the next few years. It will grow to $2.88 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to rising demand for outpatient procedures, anesthesia delivery systems, telemedicine and remote monitoring, growing prevalence of respiratory disorders, expansion of ambulatory surgery centers. Major trends in the forecast period include non-pharmacological alternatives, sustainability and eco-friendly practices, data integration and artificial intelligence, and advancements in medical technology.

The swift action and brief duration of inhalation sedatives are anticipated to propel the inhalation sedative market. Their rapid onset and quick recovery make them suitable for short medical procedures, notably in pediatric dental surgeries and intensive care units for pain management and rapid recuperation. Nitrous oxide, the commonly used inhalation sedative, typically administered as a 30-70% oxygen mix, takes 1-2 minutes to act and lasts for about 5 minutes. Its quick action and short duration make it the preferred sedative for dental treatments, thereby driving the demand for inhalation sedatives due to their rapid efficacy.

The rising prevalence of respiratory diseases is expected to boost the growth of the inhalation sedatives market in the future. Respiratory diseases refer to medical conditions that impact the respiratory system, which includes the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Inhalation sedatives are utilized in the management of these diseases to achieve various objectives, such as reducing anxiety, enhancing patient comfort, facilitating medical procedures, and improving breathing and overall respiratory function. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S. government agency, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, indicating a rise of 1,295 cases. Therefore, the growing incidence of respiratory diseases is likely to drive the future market for inhalation sedatives.

Leading companies in the inhalation sedatives market are introducing innovative services, such as inhalation sedation services, to enhance patient comfort. Inhalation sedation is a safe and effective method that employs sedative gases to help alleviate anxiety and discomfort during dental procedures. For instance, in November 2023, Platinum Dental Services, a dental provider based in Ghana, launched an inhalation sedation service designed to improve patient comfort by administering a blend of sedative gases that are inhaled during treatments. This technique significantly reduces anxiety and fear associated with dental visits, making it particularly beneficial for both adults and children who may feel apprehensive about dental care. By creating a safe and controlled environment, inhalation sedation allows patients to remain relaxed while still being aware and responsive during procedures, thereby promoting a positive dental experience. This innovative service aims to enhance overall patient care and encourage individuals to seek essential dental treatments without the stress often linked to traditional dental visits.

Major companies in the inhalation sedatives market are advancing innovative technologies, including systems for ICU sedation, to improve patient comfort, enhance safety during procedures, and ensure more effective management of sedation levels in critical care environments. ICU sedation involves administering sedative medications to patients in intensive care units to help manage anxiety, discomfort, and pain during critical medical situations. For example, in October 2024, Dahlhausen, a Germany-based medical technology company, introduced the MIRUSTM System, an advanced sedation technology designed specifically for inhalation sedation in patients. This system aims to enhance patient management in intensive care settings by providing effective sedation techniques that facilitate faster recovery and improve patient throughput in hospitals. The main objective is to improve the quality of sedation, reduce recovery times, and enhance resource management within healthcare facilities.

Major companies operating in the inhalation sedatives market include AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals plc, Jiangsu Hengrui Medicine Co. Ltd., Lunan Pharmaceutical Group Co. Ltd., Novartis International AG, Piramal Enterprises Ltd., Troikaa Pharmaceuticals Ltd., AstraZeneca plc, Boehringer Ingelheim International GmbH, Merck & Co. Inc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Torrent Pharmaceuticals Ltd., Aurobindo Pharma Limited, Intas Pharmaceuticals Ltd., Wockhardt Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Life Sciences Limited

North America was the largest region in the inhalation sedatives market in 2024. The regions covered in the inhalation sedatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the inhalation sedatives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The inhalation sedatives market consists of sales of halothane, fluticasone, budesonide, and ciclesonide. Values in this market are 'factory gate values,' that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inhalation Sedatives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhalation sedatives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhalation sedatives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inhalation sedatives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Sevoflurane; Desflurane; Isoflurane; Nitrous Oxide
• 2) By Application: Induction; Maintenance
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Sevoflurane: Pediatric Anesthesia; Adult Anesthesia
• 2) By Desflurane: Outpatient Surgery; Maintenance Anesthesia
• 3) By Isoflurane: Maintenance Of General Anesthesia; Induction Of General Anesthesia
• 4) By Nitrous Oxide: Analgesia For Dental Procedures; Anesthesia For Minor Surgical Procedures
• Companies Mentioned: AbbVie Inc.; Baxter International Inc.; Fresenius SE & Co. KGaA; Halocarbon Products Corporation; Hikma Pharmaceuticals plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inhalation Sedatives Market Characteristics

3. Inhalation Sedatives Market Trends And Strategies

4. Inhalation Sedatives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Inhalation Sedatives Growth Analysis And Strategic Analysis Framework

• 5.1. Global Inhalation Sedatives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Inhalation Sedatives Market Growth Rate Analysis
• 5.4. Global Inhalation Sedatives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Inhalation Sedatives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Inhalation Sedatives Total Addressable Market (TAM)

6. Inhalation Sedatives Market Segmentation

• 6.1. Global Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sevoflurane
• Desflurane
• Isoflurane
• Nitrous Oxide
• 6.2. Global Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Induction
• Maintenance
• 6.3. Global Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Other End-Users
• 6.4. Global Inhalation Sedatives Market, Sub-Segmentation Of Sevoflurane, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Anesthesia
• Adult Anesthesia
• 6.5. Global Inhalation Sedatives Market, Sub-Segmentation Of Desflurane, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Outpatient Surgery
• Maintenance Anesthesia
• 6.6. Global Inhalation Sedatives Market, Sub-Segmentation Of Isoflurane, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Maintenance Of General Anesthesia
• Induction Of General Anesthesia
• 6.7. Global Inhalation Sedatives Market, Sub-Segmentation Of Nitrous Oxide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesia For Dental Procedures
• Anesthesia For Minor Surgical Procedures

7. Inhalation Sedatives Market Regional And Country Analysis

• 7.1. Global Inhalation Sedatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Inhalation Sedatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inhalation Sedatives Market

• 8.1. Asia-Pacific Inhalation Sedatives Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inhalation Sedatives Market

• 9.1. China Inhalation Sedatives Market Overview
• 9.2. China Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inhalation Sedatives Market

• 10.1. India Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inhalation Sedatives Market

• 11.1. Japan Inhalation Sedatives Market Overview
• 11.2. Japan Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inhalation Sedatives Market

• 12.1. Australia Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inhalation Sedatives Market

• 13.1. Indonesia Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inhalation Sedatives Market

• 14.1. South Korea Inhalation Sedatives Market Overview
• 14.2. South Korea Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inhalation Sedatives Market

• 15.1. Western Europe Inhalation Sedatives Market Overview
• 15.2. Western Europe Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inhalation Sedatives Market

• 16.1. UK Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inhalation Sedatives Market

• 17.1. Germany Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inhalation Sedatives Market

• 18.1. France Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inhalation Sedatives Market

• 19.1. Italy Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inhalation Sedatives Market

• 20.1. Spain Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inhalation Sedatives Market

• 21.1. Eastern Europe Inhalation Sedatives Market Overview
• 21.2. Eastern Europe Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inhalation Sedatives Market

• 22.1. Russia Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inhalation Sedatives Market

• 23.1. North America Inhalation Sedatives Market Overview
• 23.2. North America Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inhalation Sedatives Market

• 24.1. USA Inhalation Sedatives Market Overview
• 24.2. USA Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inhalation Sedatives Market

• 25.1. Canada Inhalation Sedatives Market Overview
• 25.2. Canada Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inhalation Sedatives Market

• 26.1. South America Inhalation Sedatives Market Overview
• 26.2. South America Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inhalation Sedatives Market

• 27.1. Brazil Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inhalation Sedatives Market

• 28.1. Middle East Inhalation Sedatives Market Overview
• 28.2. Middle East Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inhalation Sedatives Market

• 29.1. Africa Inhalation Sedatives Market Overview
• 29.2. Africa Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inhalation Sedatives Market Competitive Landscape And Company Profiles

• 30.1. Inhalation Sedatives Market Competitive Landscape
• 30.2. Inhalation Sedatives Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Halocarbon Products Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hikma Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

31. Inhalation Sedatives Market Other Major And Innovative Companies

• 31.1. Jiangsu Hengrui Medicine Co. Ltd.
• 31.2. Lunan Pharmaceutical Group Co. Ltd.
• 31.3. Novartis International AG
• 31.4. Piramal Enterprises Ltd.
• 31.5. Troikaa Pharmaceuticals Ltd.
• 31.6. AstraZeneca plc
• 31.7. Boehringer Ingelheim International GmbH
• 31.8. Merck & Co. Inc.
• 31.9. Pfizer Inc.
• 31.10. Sanofi S.A.
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Sun Pharmaceutical Industries Ltd.
• 31.13. Lupin Limited
• 31.14. Cipla Limited
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Inhalation Sedatives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inhalation Sedatives Market

34. Recent Developments In The Inhalation Sedatives Market

35. Inhalation Sedatives Market High Potential Countries, Segments and Strategies

• 35.1 Inhalation Sedatives Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Inhalation Sedatives Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Inhalation Sedatives Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer